Sergei Gryaznov
Fortune : 66 976 $ au 30/06/2026
Fortune : 66 976 $ au 30/06/2026
Sergei M.
Gryaznov is the founder of Lynx Therapeutics, Inc. (1993).
Current job includes Chief Scientific Officer at MAIA Biotechnology, Inc. (2019 - present).
Former jobs include Chemistry Director at Geron Corp.
(2013) and Chief Technology Officer at Exicure Operating Co. Education includes graduate and doctorate degrees from Moscow State University Lomonosov.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 46 511 ( 0,08% ) | 66 976 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/12/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 01/01/2013 |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Corporate Officer/Principal | 01/01/1997 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Moscow State University Lomonosov
Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops cancer therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national